National Health Investors, Inc.
NHI
$73.73
$0.320.44%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 277.00M | 275.88M | 271.60M | 267.10M | 268.24M |
| Total Other Revenue | 156.84M | 127.30M | 106.17M | 88.95M | 80.83M |
| Total Revenue | 433.84M | 403.19M | 377.77M | 356.05M | 349.07M |
| Cost of Revenue | 112.22M | 87.70M | 70.50M | 58.11M | 52.77M |
| Gross Profit | 321.62M | 315.49M | 307.27M | 297.94M | 296.30M |
| SG&A Expenses | 31.48M | 29.44M | 29.53M | 27.75M | 26.35M |
| Depreciation & Amortization | 91.11M | 85.48M | 80.94M | 77.97M | 75.52M |
| Other Operating Expenses | 996.00K | 1.03M | 1.08M | 850.00K | 689.00K |
| Total Operating Expenses | 235.81M | 203.64M | 182.06M | 164.68M | 155.34M |
| Operating Income | 198.03M | 199.55M | 195.71M | 191.37M | 193.73M |
| Income Before Tax | 166.12M | 146.72M | 140.79M | 145.77M | 141.54M |
| Income Tax Expenses | 732.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | 165.39 | 146.72 | 140.79 | 145.77 | 141.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.41M | 1.39M | 1.39M | 1.49M | 1.40M |
| Net Income | 166.80M | 148.11M | 142.18M | 147.26M | 142.93M |
| EBIT | 198.03M | 199.55M | 195.71M | 191.37M | 193.73M |
| EBITDA | 289.14M | 285.03M | 276.65M | 269.34M | 269.26M |
| EPS Basic | 3.47 | 3.11 | 3.03 | 3.19 | 3.15 |
| Normalized Basic EPS | 1.84 | 1.89 | 1.87 | 1.83 | 1.88 |
| EPS Diluted | 3.46 | 3.10 | 3.02 | 3.17 | 3.13 |
| Normalized Diluted EPS | 1.84 | 1.89 | 1.87 | 1.82 | 1.87 |
| Average Basic Shares Outstanding | 191.85M | 190.10M | 187.50M | 184.96M | 181.01M |
| Average Diluted Shares Outstanding | 192.55M | 190.88M | 188.21M | 185.76M | 182.12M |
| Dividend Per Share | 3.68 | 3.66 | 3.64 | 3.62 | 3.60 |
| Payout Ratio | 105.26% | 116.81% | 119.36% | 112.14% | 112.99% |